Genetic determinants of responsiveness to antiplatelet therapy
Authors:
- Brian G. KralBKBrian G. Kral
- Lookman LawalLLLookman Lawal
- Lewis C. BeckerLBLewis C. Becker
- 23 November 2008
- journal article
- Published by Springer Nature in Current Cardiovascular Risk Reports
- Vol. 2 (6) , 476-484
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- A Novel Variant in the Platelet Endothelial Aggregation Receptor-1 Gene Is Associated With Increased Platelet AggregabilityArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Pharmacogenetics of aspirin resistance: a comprehensive systematic reviewBritish Journal of Clinical Pharmacology, 2008
- Gene sequence variations of the platelet P2Y12 receptor are associated with coronary artery diseaseBMC Medical Genetics, 2007
- Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotypeNature Medicine, 2007
- Detection of functional differences between different platelet membrane glycoprotein Ibα variable number tandem repeat and Kozak genotypes as shown by the PFA-100 system: Figure 1Heart, 2006
- Variability in Platelet Aggregation Following Sustained Aspirin and Clopidogrel Treatment in Patients With Coronary Heart Disease and Influence of the 807 C/T Polymorphism of the Glycoprotein Ia GeneThe American Journal of Cardiology, 2005
- Biological Assessment of Aspirin Efficacy on Healthy IndividualsStroke, 2005
- Cyclooxygenase 1(COX1) polymorphisms in African-American and caucasian populationsHuman Mutation, 2002
- Platelet membrane glycoprotein Ibα gene −5T/C Kozak sequence polymorphism as an independent risk factor for the occurrence of coronary thrombosisHeart, 2002
- Association of two silent polymorphisms of platelet glycoprotein la/lla receptor with risk of myocardial infarction: a case-control studyThe Lancet, 1999